Home › NDC Lookup › Ingredients › Dextromethorphan Hbr Guaifenesin › 70000-0670-01
🧴image loading
(from DailyMed)

Tussin DM Dextromethorphan HBr, Guaifenesin 20 mg/20mL; 200 mg/20mL Solution — NDC 70000-0670-1 (Billing 70000-0670-01)

by Cardinal Health 110, LLC. DBA Leader · 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC

This is a package of Tussin DM Dextromethorphan HBr, Guaifenesin 20 mg/20mL; 200 mg/20mL Solution from Cardinal Health 110, LLC. DBA Leader, marketed since Feb 2025 and currently FDA-listed; retail pharmacies pay about $0.0207 per mL (NADAC). It is this product's only package size.

NDC 70000-0670-01
🏷️ FDA NDC (as labeled) 70000-0670-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0670-1
Product NDC 70000-0670
11-digit billing NDC 70000067001
NCPDP billing unit ML — per mL (volume)
RxCUI 1790650
UNII 9D2RTI9KYH, 495W7451VQ
Application # M012
SPL Set ID ebfcb699-3369-4697-9841-44015b1c9808
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-02-24
Route ORAL
Dosage form SOLUTION
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43997002520924
GCN Seq No 079414
GCN 45903
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name TUSSIN DM 200-20 MG/20 ML LIQ
FDB brand name Tussin Dm
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 079414
  • GCN: 45903
  • GPI-14 (Medi-Span): 43997002520924
  • HICL (First Databank): 000223
  • AHFS class code: 48:08.00.00
  • RxCUI (RxNorm): 1790650
Why two NDCs? The FDA registers this code as 70000-0670-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0670-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TUSSIN DM 200-20 MG/20 ML LIQ Ingredient Guaifenesin/Dextromethorphan
📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.021 $2.44 / 118 ml
Medicaid paysCMS SDUD · 12 mo $0.0803 $9.48 / 118 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.021 $0.020
▲ Up 2% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0670-01 You're viewing this Main listing 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC 2025-02-24 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Dye Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0783-34 AMERISOURCE 1 bottle $0.015 — Availability likely save 29%
rugby cough syrup 20 mg/20mL; 200 mg/20mL 00536-1348-97 Rugby 1 bottle $0.017 — Availability likely save 19%
Tussin DM 200 mg/20mL; 20 mg/20mL 70677-1185-01 Strategic 1 bottle $0.020 — Availability likely save 2%
good sense tussin dm 20 mg/20mL; 200 mg/20mL 00113-1725-26 L. 1 bottle $0.021 — Availability likely —
robafen dm 20 mg/20mL; 200 mg/20mL 00904-7223-20 Major 1 bottle $0.021 — Availability likely —
Robafen DM Cough 20 mg/20mL; 200 mg/20mL 00904-7441-20 Major 1 bottle $0.021 — Availability likely —
good neighbor pharmacy adult tussin DM 20 mg/20mL; 200 mg/20mL 46122-0704-26 Amerisource 1 bottle $0.021 — Availability likely —
Good Neighbor Sugar Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0782-29 AMERISOURCE 1 bottle $0.021 — Availability likely —
Tussin DM 20 mg/20mL; 200 mg/20mLthis 70000-0670-01 Cardinal 1 bottle $0.021 — Availability likely —
foster and thrive adult tussin dm 20 mg/20mL; 200 mg/20mL 70677-1035-01 Strategic 1 bottle $0.021 — Availability likely —
Tussin DM 20 mg/20mL; 200 mg/20mL 70677-1261-01 Strategic 1 bottle $0.021 — Availability likely —
QCH Adult Tussin DM 542 20 mg/20mL; 200 mg/20mL 83324-0023-04 Chain 1 bottle $0.021 — Availability likely —
QCH Adult Tussin DM Sugar free 545 20 mg/20mL; 200 mg/20mL 83324-0025-04 Chain 1 bottle $0.021 — Availability likely —
Childrens Robitussin Cough and Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8702-13 Haleon 1 bottle — — FDA listed —
Robitussin Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00031-8757-12 Haleon 1 bottle — — FDA listed —
Robitussin Sugar-Free Dye-Free Cough Plus Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8759-12 Haleon 1 bottle — — FDA listed —
Childrens Robitussin Honey Cough and Chest Congestion DM 10 mg/10mL; 100 mg/10mL 00031-8760-12 Haleon 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 00363-1603-26 Walgreen 1 bottle — — FDA listed —
Walgreen Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00363-7440-08 WALGREEN 1 bottle — — FDA listed —
Walgreens Grape Flavor 20 mg/20mL; 200 mg/20mL 00363-7470-04 WALGREENS 1 bottle — — FDA listed —
tussin cough and chest congestion 20 mg/20mL; 200 mg/20mL 11822-1630-00 Rite 1 bottle — — FDA listed —
equaline adult tussin 20 mg/20mL; 200 mg/20mL 41163-0813-26 United 1 bottle — — FDA listed —
Robafen Dm 20 mg/20mL; 200 mg/20mL 50090-6747-00 A-S 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 50090-7257-00 A-S 1 bottle — — FDA listed —
Cough And Chest Congestion 20 mg/20mL; 200 mg/20mL 51316-0082-34 CVS 1 bottle — — FDA listed —
Cough And Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0473-34 CVS 1 bottle — — FDA listed —
Cvs Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0744-08 CVS 1 bottle — — FDA listed —
dg health adult tussin 20 mg/20mL; 200 mg/20mL 55910-0776-26 Dolgencorp 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 56062-0607-26 Publix 1 bottle — — FDA listed —
tussin 20 mg/20mL; 200 mg/20mL 59640-0100-26 H 1 bottle — — FDA listed —
Premier Value 20 mg/20mL; 200 mg/20mL 68016-0744-04 PHARMACY 1 bottle — — FDA listed —
DRx Choice Children daytime Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 68163-0747-04 RARITAN 1 bottle — — FDA listed —
robafen dm 20 mg/20mL; 200 mg/20mL 68788-8268-01 Preferred 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 68788-8300-01 Preferred 1 bottle — — FDA listed —
rugby cough syrup 20 mg/20mL; 200 mg/20mL 68788-8303-01 Preferred 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 69842-0513-26 CVS 1 bottle — — FDA listed —
leader tussin dm 20 mg/20mL; 200 mg/20mL 70000-0596-01 Cardinal 1 bottle — — FDA listed —
Tussin DM Cough plus Chest Congestion 20 mg/20mL; 200 mg/20mL 70000-0713-01 Cardinal 1 bottle — — FDA listed —
basic care tussin dm 20 mg/20mL; 200 mg/20mL 72288-0631-26 Amazon.com 1 bottle — — FDA listed —
careone tussin dm 20 mg/20mL; 200 mg/20mL 72476-0630-26 Retail 1 bottle — — FDA listed —
topcare tussin dm 20 mg/20mL; 200 mg/20mL 76162-0600-26 Topco 1 bottle — — FDA listed —
adult cough and chest congestion 20 mg/20mL; 200 mg/20mL 79481-0063-00 Meijer, 1 bottle — — FDA listed —
Meijer Children Cough and Chest Congestion DM Grape Flavor 20 mg/20mL; 200 mg/20mL 79481-7470-08 MEIJER 1 bottle — — FDA listed —
equate adult cough and chest congestion dm 20 mg/20mL; 200 mg/20mL 79903-0095-08 WALMART 1 bottle — — FDA listed —
Tussin DM 20 mg/20mL; 200 mg/20mL 83324-0327-04 Chain 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Feb 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.
  • UNII B22547B95K
    A salt derived from citric acid that helps maintain the proper acid-base balance in the medicine. It's used as a buffer to keep the product stable and at the right pH level.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesanhydrous citric acid, flavors, glycerin, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium citrate dihydrate, sucralose, xanthan gum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCardinal Health 110, LLC. DBA Leader
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedFeb 2025
Product typeHuman Otc Drug
Portfolio163 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

⏱️ Dosage and Administration 46 words ▾

Directions do not take more than directed do not take more than 6 doses in any 24-hour period mL = milliliter only use the dose cup provided adults and children 12 years and over: 20 mL every 4 hours children under 12 years: do not use

⚠️ Warnings 151 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema Stop use and ask a doctor if cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache.

These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 27 words ▾

Other information each 20 mL contains: sodium 8 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) see end flap for expiration date and lot number

🧪 Active Ingredient 13 words ▾

Active ingredients (in each 20 mL) Dextromethorphan HBr 20 mg Guaifenesin 200 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients anhydrous citric acid, flavors, glycerin, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium citrate dihydrate, sucralose, xanthan gum

🎯 Purpose 4 words ▾

Purpose Cough suppressant Expectorant

📄 Do Not Use 55 words ▾

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 30 words ▾

Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema

📄 Stop Use and Ask a Doctor If 34 words ▾

Stop use and ask a doctor if cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-426-9391

📄 Package Label / Principal Display Panel 187 words ▾

Principal display panel LEADER♥ ™ NDC 70000-0670-1 Sugar-Free Tussin DM Cough + Chest Congestion DM Dextromethorphan HBr Guaifenesin Cough Suppressant | Expectorant Cool Mint Flavor Controls Cough Relieves Chest Congestion Thins & Loosens Mucus Dye-Free Oral Solution For Ages 12 & Over COMPARE TO ROBITUSSIN ® SUGAR-FREE DYE-FREE COUGH + CHEST CONGESTION DM active ingredients* 100% Money Back Guarantee 4 FL OZ (118 mL) TAMPER EVIDENT: DO NOT USE IF PRINTED NECK WRAP IS BROKEN OR MISSING *This product is not manufactured or distributed by Haleon US Holdings LLC, owner of the registered trademark Robitussin ® Sugar-Free Dye-Free Cough+Chest Congestion DM.

50844 ORG062307336 PARENTS: Learn about teen medicine abuse www.StopMedicineAbuse.org Cardinal Health™ DISTRIBUTED BY CARDINAL HEALTH DUBLIN, OHIO 43017 www.myleader.com 1-800-200-6313 Essential to Care™ since 1979 ©2024 Cardinal Health. All Rights Reserved. CARDINAL HEALTH, the Cardinal Health LOGO, ESSENTIAL TO CARE, LEADER, and the LEADER LOGO are trademarks or registered trademarks of Cardinal Health.

All other marks are the property of their respective owners. ✔ All LEADER™ Brand Products Have A 100% Money Back Guarantee Return to place of purchase if not satisfied. Leader 44-073 Leader 44-073

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q3 2025 – Q1 2026 · 3 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
60
Units reimbursed last 4 qtrs
12.4K
Gross reimbursed last 4 qtrs
$993.29
Avg / prescription
$16.55
Avg / unit
$0.0803
Latest quarter Q1 2026
33Rx
Medicaid pays / mL
$0.0803
gross reimbursed
vs
NADAC / mL
$0.0207
acquisition cost
=
Spread
+$0.0596
+288% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 60 Rx Managed care · 0 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 12,372 units · 31.8 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
31.831.8
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 31.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 70000-0669-01 · Cardinal 70000-0672-01 · Leader/ →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.